Mainz Biomed B.V. (MYNZ) has released an update.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Mainz Biomed announced a 1-for-40 reverse stock split to maintain its Nasdaq listing, aiming to boost its stock price and attract investors. The reverse split, effective December 3, 2024, will adjust the trading price of its shares but leave shareholder ownership percentages unchanged. This move comes after failing to meet Nasdaq’s minimum bid price and stockholders’ equity requirements.
For further insights into MYNZ stock, check out TipRanks’ Stock Analysis page.